Dirk Pikaart, DO
Gynecologic Oncology · Colorado Springs, CONPI 1285671420
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,176 of the $4,816 with a category attached, or 86.7%. Intuitive Surgical accounts for 86.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $4,349 and has fallen 94.9% since, to $223 in 2025.
Across 24 payments — averaging $200.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- AstraZeneca$178
- Genentech USA, Inc.$156
- Merck$76
- Caris MPI, Inc.$58
- Hologic Sales And Service, LLC$47
- plus $151 from 6 others
What the payments were for
- Food & beverage$64013%
- Education$4,17687%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 2 | $4,150 |
| AstraZeneca | 4 | $178 |
| Genentech USA, Inc. | 2 | $156 |
| Merck | 3 | $76 |
| Caris MPI, Inc. | 2 | $58 |
| Hologic Sales And Service, LLC | 2 | $47 |
| Genmab U.S., Inc. | 2 | $41 |
| AbbVie | 2 | $38 |
| Tesaro, Inc. | 1 | $23 |
| Clovis Oncology, Inc. | 2 | $20 |
| Immunogen, Inc. | 1 | $18 |
| Coopersurgical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,150
How this compares
$4,816 in reported general payments places this provider in the 60th percentile of 28 gynecologic oncology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Megestrol Acetate | 12 | $2,774 |
| Tamoxifen Citrate | 16 | $416 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $118 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Colorado Springs
- Jeffrey JamesLone Tree$175K
- Bradley CorrAurora$70K
- Robin LacourGreeley$64K
- John CurtinDenver$42K
- Saketh GuntupalliAurora$39K
- Kevin DavisEnglewood$32K
- Glenn BigsbyLittleton$12K
- Carolyn LefkowitsAurora$11K
- Kian BehbakhtAurora$10K
- Christine WalshAurora$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.